ESR1 and breast cancer: Despite that HR signaling has been proved to participate in bone metastasis, varied ER and PR statuses in breast cancer have been demonstrated to associate with distinct characteristics and survival and thus may exert different bone metastasis-forming capacities and lead to different survival outcomes.